Severe Hypertriglyceridemia Market Set for Growth During the Forecast Period (2026-2036) Following Approval of Ionis' TRYNGOLZA and Emergence of Novel Therapies | DelveInsight
The severe hypertriglyceridemia market is expected to experience steady growth, driven by the rising prevalence of obesity, diabetes, metabolic syndrome, and other cardiometabolic disorders associated with elevated triglyceride levels. Additionally, the expected launch of emerging...
Covered in this story
Call it yourself
No calls on $ASB yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Associated Bancorp →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.